13 Ventures - Unicorn Nest

13 Ventures

Headquarters Location

United States, Charlottesville


The main office of this VC is situated in Charlottesville. The fund is located in United States, North America.

Moreover, a start-up needs to be 2-3 years old to get investment from this fund. We can highlight the most popular investment areas for this fund, such as Biotechnology, Life Science. In addition, there are 2 more industries where it has achieved success. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. Palvella Therapeutics is among the most popular portfolio start-up of the fund.

The usual method for the fund is to invest in rounds with 2 other investors. The fund often co-invests with BioAdvance. The investor in the following rounds is usually Ligand Pharmaceuticals.

The fund generally invests in less than 2 deals every year. The fund's activity peaked in 2017.

The fund was established by Kevin Eisenfrats.

Fund Activity

Not operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing Together


Funds Investing in Following

Ligand Pharmaceuticals

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: